AskBorsa

Medical Packaging results, Q2 2025

Net profit, assets, equity and cash flow for Q2 2025, against the same period a year earlier, from the published financial statements.

Net profit9.95 millionEGP · −72.8% vs the same period a year earlier
Operating cash flow10.06 millionEGP · −58.3% vs the same period a year earlier

In short

  • Medical Packaging's net profit for Q2 2025 was about 9.95 million EGP, down −72.8% from 36.58 million EGP in Q2 2024.
  • Operating cash flow for Q2 2025 was positive at 10.06 million EGP.
Source: the Q2 2025 financial statements

Key lines against the same period a year earlier

This periodQ2 2024Change
Net profit9.95 million36.58 million−72.8%
Gross profit12.73 million57.32 million−77.8%
Total assets—233 million—
Total liabilities—38.05 million—
Shareholders' equity—195 million—
Total liabilities and equity—233 million—
Operating cash flow10.06 million24.15 million−58.3%
Investing cash flow-4.71 million-15.8 million+70.2%
Financing cash flow-1.49 million33.4 million−104.4%
Net change in cash3.87 million41.75 million−90.7%

Figures in EGP from the published statement summaries (consolidated where the company publishes consolidated statements), after normalising reporting units across periods. The exact figure is in the attached report, which may be the standalone version. Figures are as shown in the published statement summary; quarterly figures may be cumulative from the start of the fiscal year.

Official report (PDF)All of Medical Packaging's statements, five yearsAsk the AI analyst about MEPA

Medical Packaging's Q3 2026 results, the day they are published

One email on the day, no account, and a one-click stop in the email itself.

orFollow on TelegramEvery result as it lands, in the @askborsa channel

By subscribing you agree to receive these alerts only. Privacy policy

Other periods for Medical Packaging